文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

阿片类药物药理学

Opioid pharmacology.

作者信息

Trescot Andrea M, Datta Sukdeb, Lee Marion, Hansen Hans

机构信息

University of Florida, Gainesville, FL 32606, USA.

出版信息

Pain Physician. 2008 Mar;11(2 Suppl):S133-53.


DOI:
PMID:18443637
Abstract

BACKGROUND: Mu agonists have been an important component of pain treatment for thousands of years. The usual pharmacokinetic parameters (half-life, clearance, volume of distribution) of opioids have been known for some time. However, the metabolism has, until recently, been poorly understood, and there has been recent interest in the role of metabolites in modifying the pharmacodynamic response in patients, in both analgesia and adverse effects. A number of opioids are available for clinical use, including morphine, hydromorphone, levorphanol, oxycodone, and fentanyl. Advantages and disadvantages of various opioids in the management of chronic pain are discussed. OBJECTIVE: This review looks at the structure, chemistry, and metabolism of opioids in an effort to better understand the side effects, drug interactions, and the individual responses of patients receiving opioids for the treatment of intractable pain. CONCLUSION: Mu receptor agonists and agonist-antagonists have been used throughout recent medical history for the control of pain and for the treatment of opiate induced side effects and even opiate withdrawal syndromes.

摘要

背景:数千年来,μ阿片受体激动剂一直是疼痛治疗的重要组成部分。阿片类药物的常用药代动力学参数(半衰期、清除率、分布容积)已为人所知有一段时间了。然而,直到最近,其代谢情况仍知之甚少,并且最近人们对代谢产物在改变患者药效学反应(包括镇痛和不良反应)中的作用产生了兴趣。有多种阿片类药物可供临床使用,包括吗啡、氢吗啡酮、左啡诺、羟考酮和芬太尼。本文讨论了各种阿片类药物在慢性疼痛管理中的优缺点。 目的:本综述探讨阿片类药物的结构、化学和代谢,以便更好地理解接受阿片类药物治疗顽固性疼痛患者的副作用、药物相互作用及个体反应。 结论:在近代医学史上,μ受体激动剂和激动 - 拮抗剂一直被用于控制疼痛、治疗阿片类药物引起的副作用甚至阿片类药物戒断综合征。

相似文献

[1]
Opioid pharmacology.

Pain Physician. 2008-3

[2]
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pain Pract. 2008

[3]
Mu opioid receptor antagonists: recent developments.

ChemMedChem. 2007-11

[4]
Low efficacy opioids: implications for sex differences in opioid antinociception.

Exp Clin Psychopharmacol. 2006-2

[5]
Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.

Basic Clin Pharmacol Toxicol. 2008-11

[6]
Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.

Anesthesiology. 2008-8

[7]
Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.

Acta Anaesthesiol Belg. 2002

[8]
Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.

Neurosci Lett. 2009-10-2

[9]
The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.

Anesth Analg. 2008-7

[10]
[Use of opioids in the elderly -- pharmacokinetic and pharmacodynamic considerations].

Anasthesiol Intensivmed Notfallmed Schmerzther. 2004-9

引用本文的文献

[1]
Real-World Effectiveness of a Novel AI-Software Dependent Neuromodulation (ASDN) with Remote Monitoring Capability Field Stimulation Device for Chronic Pain: A 24-Month Analysis of Over 2000 Patients.

J Pain Res. 2025-8-23

[2]
Optimization of postoperative pain management in gynecological laparoscopic surgery with combined Nalbuphine and Remifentanil: A retrospective analysis with propensity score matching.

Medicine (Baltimore). 2025-8-15

[3]
Effect of analgesic treatments on voluntary activity, mechanical sensitivity and muscle regeneration after cardiotoxin injection in mice.

Sci Rep. 2025-7-31

[4]
Evaluating the drug interactions in kratom usage: clinical application.

Expert Opin Drug Metab Toxicol. 2025-6-22

[5]
Persistent Transcriptome Alterations in Zebrafish Embryos After Discontinued Opioid Exposure.

Int J Mol Sci. 2025-5-19

[6]
Ethical interventions: revisiting the assessment tools for health-system pharmacists.

Front Med (Lausanne). 2025-4-11

[7]
The Impact of Fentanyl and Morphine on Maternal Hemodynamics in Spinal Anesthesia for Cesarean Section.

Pharmaceuticals (Basel). 2025-3-11

[8]
Evaluation of the Antinociceptive Effect of Sesamin: Role of 5HT Serotonergic Receptors.

Pharmaceutics. 2025-3-3

[9]
Genetic Variation and Sex-Based Differences: Current Considerations for Anesthetic Management.

Curr Issues Mol Biol. 2025-3-18

[10]
Pharmacokinetics and Bioavailability of Single-Dose Intramuscular and Intravenous Administration of Thiafentanil in Goats (Capra hircus).

J Vet Pharmacol Ther. 2025-3-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索